Ekaterina Nevedomskaya
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Protein Language Model-Based Fitness Estimates Facilitate Resistance Mutation Identification.
Journal: Journal of chemical information and modeling
Published: July 13, 2026
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review.
Journal: International journal of molecular sciences
Published: November 14, 2023
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.
Journal: Molecular oncology
Published: August 08, 2023
Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven Programs.
Journal: European urology
Published: January 16, 2023
Targeting fatty acid oxidation via Acyl-CoA binding protein hinders glioblastoma invasion.
Journal: Cell death & disease
Published: July 25, 2022
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.
Journal: International journal of molecular sciences
Published: April 19, 2022
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 16, 2020
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
Journal: Molecular oncology
Published: January 27, 2020
Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target.
Journal: Cancers
Published: December 12, 2019
Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program.
Journal: Endocrine-related cancer
Published: November 26, 2019
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer.
Journal: Scientific reports
Published: August 15, 2019
Last Updated: 09/26/2026